Vicenzi MN, Ribitsch D, Luha O, Klein W, Metzler H (2001) Coronary artery stenting before noncardiac surgery: more threat than safety? Anaesthesiology 94:367–368CrossRef 15. Reddy PR, Vaitkus PT (2005) Risks of noncardiac surgery after coronary stenting. Am J Cardiol 95:755–757CrossRefPubMed 16. Brown MJ, Long TR, Brown DR, Wass CT (2006) Acute coronary syndrome and myocardial infarction after orthopaedic surgery in a patient with a recently placed drug-eluting stent. J Clin Anesth 18:537–540CrossRefPubMed 17. Lecompte
T, Hardy J-F (2006) Antiplatelet agents and perioperative bleeding. Can J Anaesth 53(6 Suppl):S103–S112PubMed 18. Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof E, Fleishmann KE, Freeman WK, Froehlich
JB, Apoptosis inhibitor Kasper E, Kersten JR, Riegel B, Robb JF (2007) ACC/AHA 2007 Guidelines on perioperative https://www.selleckchem.com/products/GSK690693.html cardiovascular evaluation and care for noncardiac surgery. A report of the buy Tozasertib American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Circulation 116:e418–e499CrossRefPubMed 19. Collet JP, Montalescot G (2006) Premature withdrawal and alternative therapies to dual oral antiplatelet therapy. Eur Heart J Suppl 8(Suppl):G46–G52CrossRef 20. Charbucinska KN, Godet G, Itani O, Fleron NJ, Bertrand M, Rienzo M, Coriat P (2006) Anticoagulation management for patients with drug-eluting stents undergoing vascular surgery. Anesth Analg 103:261–263CrossRefPubMed 21. Albaladejo P, Marret E, Piriou V, Samama CM (2006) French Society of Anesthesiology and Intensive Care. Management of oral antiplatelet agents in patients with coronary stents: recommendations of a French Task Force. Ann Fr Anesth Reanim 25(7):796–798PubMed Demeclocycline 22. Chassot P-G, Delabays A, Spahn DR (2007) Perioperative antiplatelet therapy: the case for continuing therapy in patients at risk of myocardial infarction. Br J Anaesth 99:316–328CrossRefPubMed 23. Broad L, Lee T, Conroy M, Bolsin S, Orford N, Black A, Birdsey G
(2007) Successful management of patients with a drug-eluting coronary stent presenting for elective, non-cardiac surgery. Br J Anaesth 98:19–22CrossRefPubMed 24. Brilakis ES, Banerjee S, Berger PB (2007) Perioperative management of patients with coronary stents. J Am Coll Cardiol 49:2145–2150CrossRefPubMed 25. Geerts WH, Pineo GF, Heit JA et al (2004) Prevention of venous thromboembolism: the Seventh ACCP Conference of Antithrombotic and Thrombolytic Therapy. Chest 126:338SCrossRefPubMed 26. Geerts WH, Bergqvist D, Pineo GF et al (2008) Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133:381SCrossRefPubMed 27. Eriksson BI, Bauer KA, Lassen MR, Turpie AG (2001) Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery.